Heart Failure

Women with a history of cardiotoxicity from previous cancer treatments are around 30 percent more likely to experience clinical congestive heart failure (CHF) before, during or after pregnancy, according to research published ahead of print this week in the Journal of the American College of Cardiology.
Thumbnail
Digoxin, a cardiac glycoside popularly sold under the brand name Lanoxin, poses a major threat to…
Thumbnail
Women who suffer from peripartum cardiomyopathy (PPCM) will likely be clinically asymptomatic seven…
Thumbnail
The Hospital Readmissions Reduction Program (HRRP) has successfully slashed readmissions for heart…
Thumbnail
Heart failure (HF) patients who experience moderate functional mitral regurgitation (FMR) for at…
Thumbnail
SAN DIEGO — Compared to heart failure patients with severe secondary mitral regurgitation who were…
Thumbnail
Digital games developed for cardiovascular disease self-management improve exercise capacity and…